Cabot Corporation
CBT Basic Materials Specialty Chemicals
Cabot Corporation’s revenue for fiscal 2025 (year ended September 2025) was $3.7 billion, down 7.04% from fiscal 2024.
- Revenue
- +12.2%
- EPS
- +79.4%
- Free cash flow
- −51.7%
- Total debt
- +10.8%
Quarter to September 2026, against a year earlier
Follow CBT
Alert me
Cabot Corporation (CBT) P/E ratio
As of 5 November 2026, Cabot Corporation (CBT) trades at a P/E ratio of 17.4×. Over the past ten years it has ranged from 0.0× (September 2021) to 69.9× (January 2018); the current reading is higher than 70% of that period. That is below the Specialty Chemicals industry median of 24.5× and below the Basic Materials sector median of 19.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 12.5× | (24.32%) |
| FY2024 | 16.6× | 88.89% |
| FY2023 | 8.8× | (50.53%) |
| FY2022 | 17.7× | 53.68% |
| FY2021 | 11.5× | — |
| FY2020 | 0.0× | — |
| FY2019 | 17.2× | — |
| FY2018 | 0.0× | — |
| FY2017 | 15.1× | (32.17%) |
| FY2016 | 22.2× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 18.4× | (28.01%) |
| Jun 2026 | 25.5× | 79.88% |
| Mar 2026 | 14.2× | 23.04% |
| Dec 2025 | 11.5× | (8.15%) |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CLMT Calumet, Inc. compare | n/m |
| FUL H. B. Fuller Company compare | 13.8× |
| CBT Cabot Corporation | 17.4× |
| AVNT Avient Corporation compare | 23.1× |
| SXT Sensient Technologies Corporation compare | 30.0× |
| HWKN Hawkins, Inc. compare | 36.6× |
| WDFC WD-40 Company compare | 37.0× |
| ASH Ashland Inc. compare | 67.1× |
| PRM Perimeter Solutions, SA compare | 102× |
| Specialty Chemicals industry median | 24.5× |
| Basic Materials sector median | 19.0× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on CBT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement